Works by Chen-Plotkin, Alice S.
Results: 35
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)".
- Published in:
- 2022
- By:
- Publication type:
- Letter
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TMEM106B. the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways.
- Published in:
- Journal of Neuroscience, 2012, v. 32, n. 33, p. 11213, doi. 10.1523/JNEUROSCI.0521-12.2012
- By:
- Publication type:
- Article
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
- Published in:
- PLoS Medicine, 2019, v. 16, n. 10, p. 1, doi. 10.1371/journal.pmed.1002931
- By:
- Publication type:
- Article
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genetic influences on cognitive decline in Parkinson's disease.
- Published in:
- Movement Disorders, 2012, v. 27, n. 4, p. 512, doi. 10.1002/mds.24946
- By:
- Publication type:
- Article
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
- Published in:
- Nature, 2010, v. 466, n. 7310, p. 1069, doi. 10.1038/nature09320
- By:
- Publication type:
- Article
Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration.
- Published in:
- Human Molecular Genetics, 2008, v. 17, n. 10, p. 1349, doi. 10.1093/hmg/ddn023
- By:
- Publication type:
- Article
An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147319
- By:
- Publication type:
- Article
Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 2, p. 255, doi. 10.1002/ana.26410
- By:
- Publication type:
- Article
Plasma apolipoprotein A1 as a biomarker for Parkinson disease.
- Published in:
- Annals of Neurology, 2013, v. 74, n. 1, p. 119, doi. 10.1002/ana.23872
- By:
- Publication type:
- Article
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 4, p. 655, doi. 10.1002/ana.22271
- By:
- Publication type:
- Article
Development and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 11, p. 1411, doi. 10.1001/jamaneurol.2013.3956
- By:
- Publication type:
- Article
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau<sub>181</sub>, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 10, p. 1277, doi. 10.1001/jamaneurol.2013.3861
- By:
- Publication type:
- Article
TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
- Published in:
- Acta Neuropathologica, 2021, v. 142, n. 4, p. 629, doi. 10.1007/s00401-021-02330-2
- By:
- Publication type:
- Article
ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
- Published in:
- Acta Neuropathologica, 2020, v. 140, n. 4, p. 449, doi. 10.1007/s00401-020-02199-7
- By:
- Publication type:
- Article
Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
- Published in:
- Acta Neuropathologica, 2010, v. 119, n. 1, p. 111, doi. 10.1007/s00401-009-0576-2
- By:
- Publication type:
- Article
Finding useful biomarkers for Parkinson's disease.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 454, p. 1, doi. 10.1126/scitranslmed.aam6003
- By:
- Publication type:
- Article
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177924
- By:
- Publication type:
- Article
Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 5, p. 1045, doi. 10.1002/ana.26635
- By:
- Publication type:
- Article
Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 13, p. 2681, doi. 10.1093/hmg/ddw127
- By:
- Publication type:
- Article
Cerebrospinal fluid α‐synuclein contributes to the differential diagnosis of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 8, p. 1052, doi. 10.1016/j.jalz.2018.02.015
- By:
- Publication type:
- Article
GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.
- Published in:
- Movement Disorders, 2024, v. 39, n. 6, p. 1065, doi. 10.1002/mds.29773
- By:
- Publication type:
- Article
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 12, p. 2945, doi. 10.1002/mds.28779
- By:
- Publication type:
- Article
Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.
- Published in:
- Movement Disorders, 2015, v. 30, n. 6, p. 805, doi. 10.1002/mds.26022
- By:
- Publication type:
- Article
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 3, p. 673, doi. 10.1002/acn3.51988
- By:
- Publication type:
- Article
Plasma phosphorylated tau181 predicts cognitive and functional decline.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 1, p. 18, doi. 10.1002/acn3.51695
- By:
- Publication type:
- Article
Genetic prediction of impulse control disorders in Parkinson's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 7, p. 936, doi. 10.1002/acn3.51569
- By:
- Publication type:
- Article
Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 1, p. 15, doi. 10.1002/acn3.371
- By:
- Publication type:
- Article
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2016, v. 3, n. 5, p. 346, doi. 10.1002/acn3.299
- By:
- Publication type:
- Article
PolyQ Repeat Expansions in ATXN2 Associated with ALS Are CAA Interrupted Repeats.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017951
- By:
- Publication type:
- Article
Age-Correlated Gene Expression in Normal and Neurodegenerative Human Brain Tissues.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0013098
- By:
- Publication type:
- Article